Kai Biotech

Kai Biotech is a South Korea-based biotechnology company focused on radiopharmaceuticals for diagnostics and therapeutics. The company appears to be developing radioactive tracers and related products for neurodegenerative disease diagnosis, especially dementia and Alzheimer's disease, as well as liver cancer and other oncology applications. Public market profiles also describe the business as engaged in medical products based on radioactive fusion technology, including radiopharmaceuticals used in the diagnosis of multiple cancers and certain therapeutic applications. Kai Biotech is listed on South Korea's KONEX market under ticker 446600 and is headquartered in Jeonju, Jeollabuk-do. Publicly available English-language detail on its pipeline is limited, so several program-specific fields below are left null or conservative.